EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

An eosinophil peroxidase activity assay predicts acute exacerbations in post‐operative chronic rhinosinusitis

Conner J Massey iD, Gretchen M Oakley, Richard R Orlandi iD, Shaelene Ashby, Jeremiah A Alt iD, Kristine A Smith, Abigail Pulsipher iD

International Forum of Allergy & Rhinology · 2024

DOI: 10.1002/alr.23366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2024. Verfasst von Conner J Massey und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Sinusitis, Rhinitis, Eosinophil Peroxidase. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Center for Advancing Translational Sciences of the National Institutes of Health under Award Numbers, NIAID NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key points EPX activity has been correlated with eCRS diagnosis and baseline disease severity. Herein, EPX activity is shown to correlate with post‐operative antibiotic and steroid use in CRS. EPX activity has potential to act as a prognostic biomarker of CRS disease severity and control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SinusitisRhinitisEosinophil PeroxidaseHumansChronic DiseaseMaleFemaleMiddle AgedBiomarkersAdultAnti-Bacterial AgentsPostoperative ComplicationsDisease ProgressionPrognosisAgedSeverity of Illness IndexRhinosinusitis

Stichwörter der Autor:innen

chronic rhinosinusitisendoscopic sinus surgeryeosinophil peroxidase

Substanzen

Eosinophil PeroxidaseBiomarkersAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Otolaryngology-Head & Neck Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Department of Molecular Pharmaceutics, University of Utah College of Pharmacy, Salt Lake City, Utah, USA.
  • Utah Center for Nanomedicine, University of Utah College of Pharmacy, Salt Lake City, Utah, USA.
  • Department of Biomedical Engineering, University of Utah College of Engineering, Salt Lake City, Utah, USA.

ORCID-Profile: Conner J Massey, Richard R Orlandi, Jeremiah A Alt, Abigail Pulsipher

Förderung

  • National Center for Advancing Translational Sciences of the National Institutes of Health under Award Numbers
  • NIAID NIH HHS
  • NCATS NIH HHS
  • Flight Attendant Medical Research Institute
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Massey, C. J., Oakley, G. M., Orlandi, R. R., Ashby, S., Alt, J. A., Smith, K. A., & Pulsipher, A. (2024). An eosinophil peroxidase activity assay predicts acute exacerbations in post‐operative chronic rhinosinusitis. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23366

Vancouver

Massey CJ, Oakley GM, Orlandi RR, Ashby S, Alt JA, Smith KA, et al. An eosinophil peroxidase activity assay predicts acute exacerbations in post‐operative chronic rhinosinusitis. International Forum of Allergy & Rhinology. 2024. doi:10.1002/alr.23366

BibTeX
@article{Massey2024,
  author = {Massey, Conner J and Oakley, Gretchen M and Orlandi, Richard R and Ashby, Shaelene and Alt, Jeremiah A and Smith, Kristine A and Pulsipher, Abigail},
  title = {An eosinophil peroxidase activity assay predicts acute exacerbations in post‐operative chronic rhinosinusitis},
  journal = {International Forum of Allergy & Rhinology},
  year = {2024},
  doi = {10.1002/alr.23366}
}
Kostenlos starten →